11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial

Treatment options for idiopathic intracranial hypertension are limited. The enzyme 11β-hydroxysteroid dehydrogenase type 1 has been implicated in regulating cerebrospinal fluid secretion, and its activity is associated with alterations in intracranial pressure in idiopathic intracranial hypertension...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Brain Commun
Main Authors: Markey, Keira, Mitchell, James, Botfield, Hannah, Ottridge, Ryan S, Matthews, Tim, Krishnan, Anita, Woolley, Rebecca, Westgate, Connar, Yiangou, Andreas, Alimajstorovic, Zerin, Shah, Pushkar, Rick, Caroline, Ives, Natalie, Taylor, Angela E, Gilligan, Lorna C, Jenkinson, Carl, Arlt, Wiebke, Scotton, William, Fairclough, Rebecca J, Singhal, Rishi, Stewart, Paul M, Tomlinson, Jeremy W, Lavery, Gareth G, Mollan, Susan P, Sinclair, Alexandra J
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7425517/
https://ncbi.nlm.nih.gov/pubmed/32954315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/braincomms/fcz050
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados